HEXO (TSX:HEXO) Stock at $10: Will Shares Double Again?

HEXO (TSX:HEXO)(NYSE:HEXO) has been one of the best cannabis stocks of 2021. Will the rise continue, or is it time to take profits?

| More on:
Marijuana plant and cannabis oil bottles isolated

Image source: Getty Images

HEXO (TSX:HEXO)(NYSE:HEXO) is one of the best-positioned pot stocks on the market. It has a validated business model that differentiates itself from the rest of the industry.

It seems like others are catching on. Since the year began, shares have nearly doubled. Is the stock still a buy at $10?

This stock was ready to roar

Last year, just before shares took off, I called HEXO the only cannabis stock worth owning right now. It wasn’t hard to connect the dots.

“To profit from this industry, you need to identify companies like Coca-Cola, which sells commoditized ingredients at a premium price simply by packaging them in a certain way,” I explained. “HEXO is not like the competition. This company isn’t trying to ramp production as quickly as possible. Instead, it’s focused on value-add products, just like Coke.”

That’s the entire investment pitch in a nutshell. In 2018, when pot stocks first took off, everyone was obsessed with raw production growth. Long-term profits, however, were most attractive for value-add producers. That’s where I urged readers to focus.

“For example, HEXO is co-producing THC-infused drinks with Molson Coors,” I wrote. “This could be a multi-billion-dollar category. Ask yourself which product consumers will flock to: a cannabis beverage made by Molson or one sold by an unknown pot startup?”

This stock was the best positioned pot producer for years. The marijuana bear market kept the valuation low, but all investors needed was another wave of enthusiasm. That’s exactly what happened at the start of 2021.

Will HEXO stock go even higher?

Predicting short-term movements in stock prices is a losing game. Ray Dalio likens it to playing poker with the best. If you want to succeed as an investor, you need to keep a long-term outlook.

What’s the long-term outlook for HEXO stock? Pretty good.

The global market for cannabis is already projected to surpass $100 billion by 2026, growing at nearly 30% per year. The biggest growth segment isn’t flowers, but value-add products like concentrates, edibles, and vapes. This is exactly where HEXO is positioned to dominate.

“Cannabis is a brand business,” explained the company’s CEO. “We’re not about commodity farming. We’re focused on developing products that offer very specific experiences and are dose-controlled, shelf-stable and delivered to the adult-use market through non-prescription channels.”

It’s this focus that will send HEXO stock higher over the long term. Even after the recent spike to $10, the business is still valued at just $1.2 billion. The value-add segment globally should be worth well above $20 billion. The only question left is how much market share HEXO will command.

There’s no doubt there’s uncertainty here. If there wasn’t, the potential upside wouldn’t be so lucrative. Two cannabis stocks will become the Coca-Cola of marijuana. These two businesses will command sky-high margins, rabid customer loyalty, and a global distribution chain that lets them win everywhere.

Will HEXO be one of those titans? No one knows for sure, but with a price tag of just $1.2 billion, this is a cheap way to get exposure.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool recommends HEXO. and HEXO. Fool contributor Ryan Vanzo has no position in any stocks mentioned.

More on Cannabis Stocks

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Steer Clear: This Stock Spells Trouble

A newly listed cannabis stock is outperforming in 2024 but investors should stay clear to avoid trouble and losses.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

2 Best Marijuana Stocks to Buy This Month

Marijuana stocks in the U.S. such as Green Thumb and Curaleaf can help you deliver outsized gains to investors in…

Read more »

A cannabis plant grows.
Cannabis Stocks

Can Aurora Cannabis Stock Recover in 2024?

Aurora Cannabis stock is down 99% from all-time highs but remains a high-risk bet, despite its cheap valuation.

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

The Best Cannabis Stock to Buy Right Now

This cannabis stock has jumped 30% in the last few months, with even more growth on the way – all…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Down 99% From All-Time Highs, Is Canopy Growth Stock a Good Buy Right Now?

Canopy Growth stock is a high-risk investment due to its negative profit margins and challenging liquidity position.

Read more »

Marijuana plant and cannabis oil bottles isolated
Stocks for Beginners

Aurora Cannabis’ Reverse Stock Split: Is the Stock a Buy Today?

Cannabis stock Aurora (TSX:ACB) is consolidating shares once again, but what does this mean for investors?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Where Will Cannabis Stocks Be in 10 Years?

Cannabis stocks could see a huge shift upwards should marijuana be rescheduled in the U.S., but you can still buy…

Read more »